Crea il mio profilo
Accesso pubblico
Visualizza tutto17 articoli
2 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Mikhail SavitskiEMBLEmail verificata su embl.de
- Isabelle BecherEMBL HeidelbergEmail verificata su embl.de
- André MateusAssistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)Email verificata su umu.se
- Marcus BantscheffCellzome, a GSK companyEmail verificata su gsk.com
- Wolfgang HuberEMBL - European Molecular Biology LaboratoryEmail verificata su embl.org
- Holger FrankenGSKEmail verificata su holgerfranken.de
- Dominic HelmProteomics Core Facility, DKFZEmail verificata su dkfz-heidelberg.de
- Nassos TypasGroup Leader, EMBLEmail verificata su embl.de
- Sindhuja SridharanECR (Lecturer), Blizard Institute, Barts and The London School of Medicine andEmail verificata su qmul.ac.uk
- Giovanna BergaminiCellzome GmbH, a GSK companyEmail verificata su GSK.com
- Martin BeckMax Planck Institute of BiophysicsEmail verificata su biophys.mpg.de
- Carl HerrmannProfessor of Bioinformatics - IPMB - Heidelberg UniversityEmail verificata su uni-heidelberg.de
- Bernhard KusterProfessor for Proteomics and BioanalyticsEmail verificata su tum.de
- Johannes F. HevlerStanford UniversityEmail verificata su stanford.edu
- Simon AndersBioquant Center, University of HeidelbergEmail verificata su fs.tum.de
- Sebastian SteinhauserNovartis Institutes for BioMedical Research - Discovery Sciences Data ScienceEmail verificata su novartis.com
- Natalie RomanovEMBL HeidelbergEmail verificata su embl.de
- Pedro BeltraoAssociate Professor, ETH ZurichEmail verificata su ethz.ch
- Karsten BachPostdoctoral researcher, ETH ZurichEmail verificata su bsse.ethz.ch
- Daniel HuebschmannClinician scientist, group leader National Center for Tumor Diseases (NCT) Heidelberg and GermanEmail verificata su dkfz-heidelberg.de